Caliway's Potential Cellulite Treatment Meets Endpoints in Phase 2 Study

Caliway Biopharmaceuticals said Thursday that its study of a potential treatment for cellulite met ... in improving cellulite severity in the phase 2 study, Caliway said. The study of CBL-524 ... Read More

Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease

The U.S. Food and Drug Administration (FDA) has granted inaxaplin Rare Pediatric Disease Designation ... About the Phase 2/3 AMPLITUDE Study Inaxaplin is a potential first-in-class ... Read More

Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis

Data support frexalimab as a potential first-in-class, high-efficacy, non-lymphocyte depleting treatment ... of study participants entered the open-label extension (OLE) of the phase 2 study. Read More

Harmony Biosciences Launches Phase 3 Trial for Potential Prader-Willi Syndrome Treatment

Kumar Budur, M.D., M.S., Chief Medical Officer of Harmony Biosciences, expressed optimism about the trial’s potential impact. “The initiation of our Phase 3 TEMPO study reflects continued ... Read More

Hepion ends Phase 2 study for NASH drug due to cash restraints

Hepion Pharmaceuticals (NASDAQ:HEPA) said it has begun winding down its ASCEND-NASH Phase 2 study for its drug rencofilstat ... testing reconfilstat for the treatment of non-alcoholic ... Read More

Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)

BIO101's (20-hydroxyecdysone) potential in the treatment of obesity in combination ... with results expected in 2025 The OBA Phase 2 clinical study is expected to start mid 2024, upon regulatory ... Read More

Pulmocide Announces Successful Results From The OPERA-S Study: A Phase 2 Safety Study With Inhaled Opelconazole

today announced topline results from the OPERA-S study: a Phase 2 safety and tolerability study in lung transplant patients receiving inhaled opelconazole monotherapy as prophylaxis against ... Read More

Biophytis announces new Scientific Advisory Board for its phase 2 OBA clinical study in obesity

The OBA SAB will guide the company to develop BIO101 (20-hydroxyecdysone) in obesity, in combination with GLP1-RA, and will actively work towards the finalization of the OBA Phase 2 clinical study ... Read More

PHASE 2

PHASE 2 is an American graffiti artist known for his pioneering role in the “bubble letter” style of spray painting. Born Michael Lawrence Marrow on August 2, 1955, in Bronx, NY, he began tagging ... Read More

Sanofi - Aventis Groupe: Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis

New 48-week frexalimab phase 2 data support ... represents a novel potential first-in-class treatment mechanism in multiple sclerosis designed to tackle the aspects of this disease where unmet ... Read More

Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)

These benefical effects of BIO101 (20-hydroxyecdysone) may translate into improved mobility and muscle strength in obese sarcopenic patients, as suggested in the SARA-INT phase 2 study ... BIO101's ... Read More

Pulmocide Announces Successful Results from the OPERA-S Study: a Phase 2 Safety Study with Inhaled Opelconazole

today announced topline results from the OPERA-S study: a Phase 2 safety and tolerability study in lung transplant patients receiving inhaled opelconazole monotherapy as prophylaxis against pulmonary ... Read More